| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77f7b59edccdb6785186198392b42b13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_401921f6e3357c1c6ed50156571c3dcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_996e9b61cd93df477ad656f7dfc3db76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
1999-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71ea8e42bf0ff0d64058b405a2d14789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16a75b7bacdeb9fecae560370f1ffb24 |
| publicationDate |
2000-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0025771-A1 |
| titleOfInvention |
Method for preventing increased iridial pigmentation during prostaglandin treatment |
| abstract |
Anti-inflammatory agents are used to prevent iridial pigmentation during prostaglandin treatment and to manufacture pharmaceuticals for this purpose. A method for preventing iridial pigmentation as well as a method for treating glaucoma is based on the concomitant or simultaneous administration of a prostaglandin or prostaglandin analogue and an anti-inflammatory agent. Both non-steroid and steroid anti-inflammatory agents can be employed according to the invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004014352-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02085248-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0205848-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009005172-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0205815-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1541151-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03002755-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7972612-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1082966-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6646001-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03002755-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02085248-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6342524-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005099715-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004014352-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1082966-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1541151-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0205848-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03051351-A1 |
| priorityDate |
1998-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |